Development of domperidone bilayered matrix type transdermal patches: Physicochemical, in vitro and ex vivo characterization

DARU, Journal of Pharmaceutical Sciences

Volumn 18, Issue 3, 2010, Pages 221-229

  Madishetti, S K ^a   Palem, C R ^a   Gannu, R ^a   Thatipamula, R P ^a   Panakanti, P K ^a   Yamsani, M R ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Bilayered Transdermal patches; Domperidone; Ex vivo permeation; In vitro release

Indexed keywords

DOMPERIDONE; LIMONENE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; EX VIVO STUDY; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SHELF LIFE; TENSILE STRENGTH;

EID: 78149449839     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chien Y.W. Transdermal therapeutic system: In controlled drug delivery fundamentals and applications. NewYork, Marcel Dekker. 1987; 524-552.
2. Kanikannan N, Andega S, Burton S, Babu R.J, Singh M. Formulation and in vitro evaluation of transdermal patches of melatonin. Drug Dev Ind Pharm, 2004; 30: 205-212.
3. Robinson J.R, Lee V.H. Controlled drug delivery fundamentals and applications. NewYork, Marcel Dekker, 1987; 524-552.
4. Barry B.W. Dermatological formulation. NewYork, Mercel Dekker, 1983; 225-238.
5. Sweetman S.C. Martindale-The complete drug reference. Pharmaceutical Press, London. (U.K), 2007; 1556-1557.
6. Gregor C, Gabriele B, Andreas S, Dieter G. The skin: a pathway for systemic treatement with patches and lipid-based agent carriers. Adv Drug Del Rev, 1996; 18: 349-378.
7. Ramesh P, Omathanu P, Vinod B.N, Ramarao P. Transdermal iontophoresis revisited. Curr Opin Chem Biol, 2000; 4: 468-473.
8. Jim E.R, Mark C.H. Electrically assisted transdermal drug delivery. Pharm Res, 1997; 14: 687-697.
9. Niclas R, Patrick G, Goran S. Membrane sealed hollow micro needles and related administration schemes for transdermal drug delivery. Biomed Micro Devices, 2008; 10: 271-279.
10. Barrie C.F, Timothy M.M. Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci, 1999; 88: 955-958.
11. Williams A.C, Barry B.W. Terpenes and the lipid-protein-protein partitioning theory of skin penetration enhancement. Pharm Res, 1991; 8: 17-24.
12. Moghimi H.R, Williams A.C, Barry B.W. A lamellar matrix model for stratum corneum intercellular lipids. Effects of terpenes penetration enhancers on the structure and thermal behaviour of the matrix. Int J Pharm, 1997; 146: 41-54.
13. Gao S, Singh J. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J Control Rel, 1998; 51: 193-199.
14. EI-Kattan A.F, Asbil C.S, Michniac B.B. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm, 2000; 198: 179-189.
15. Kaidi Z, Jagdish S. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Rel, 1999; 62: 359-366.
16. Mamatha T, Venkateswara Rao J, Mukkanti K, Ramesh G. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization. DARU, 2010; 18: 9-16.
17. Chinna Reddy P, Ramesh G, Vamshi Vishnu Y, Shravan Kumar Y, Madhusudan Rao Y. Development of bilayered mucoadhesive patches for buccal delivery of felodipine: in vitro and ex vivo characterization. Cur Trends Biotech Pharm, 2010; 4: 673-683.
18. Devi K, Saisivum S, Maria G.R, Deepti P.U. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm, 2003; 5: 495-503.
19. Gupta R, Mukharjee B. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethyl cellulose matrices. Drug Dev Ind Pharm, 2003; 29: 1-7.
20. Ramesh G, Vamshi Vishnu Y, Kishan V, Madhusudan Rao Y. Development of carvedilol transdermal patches:evaluation of physicochemical, ex vivo and mechanical properties. PDA J Pharm Sci Tech, 2008; 62: 391-401.
21. Friend D.R. In vitro skin permeation techniques. J Control Rel, 1992; 18: 235-238.
22. Franz T.J. Percutaneous absorption: on the relevance of in vitro data. J Invest Dermatol, 1975; 64: 190-196.
23. Raja J.J, Barone J.A, Byerly W.G. Determination of steady state dose proportionality of domperidone in healthy volunteers. Pharmacotherapy, 1990; 10: 253-260.
24. Singh S. Drug stability testing and shelf life determination according to International guidelines. Pharm Tech, 1999; 2368-2388.
25. Arora P, Mukherjee B. Design, development, physicochemical, in vitro and in vivo evaluation of transdermal patches containing diclofenac diethyl ammonium salt. J Pharm Sci, 2002; 9: 2076-2089.
26. Aulton M.E, Abdul-Razzak M.H, Hogan J.E. The mechanical properties of hydroxyl propyl methyl cellulose films derived from aqueous systems: the influence of solid inclusions. Drug Dev Ind Pharm, 1981; 7: 649-668.
27. Rowe R.C. Correlation between the in situ performance of tablet film coating formulations based on hydroxyl propyl methyl cellulose and data obtained from the tensile testing of free films. Acta Pharm Tech, 1983; 29: 205-207.